Waste of the Day: A Subsidized $200K/Year Cancer Drug

Topline: Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients and siphoning money away from Medicaid, a Read Full Article »